Evolus shares surge 29.54% premarket after Q4 beat and first-time net income in nearly five years.

Evolus (EOLS) surged 29.54% in premarket trading following the release of strong Q4 2025 results, including net income for the first time in nearly five years and revenue of $90.3 million, reflecting 14% year-over-year growth despite a modest revenue miss. The stock’s rally also aligned with a "Buy" rating reiterated by BTIG, maintaining a $13.00 price target. While the company’s breakeven EPS and data privacy risks were noted, the focus remained on the unexpected profitability and analyst optimism, which outweighed concerns about the revenue shortfall.